Walter, R. B., Gyurkocza, B., Storer, B. E., Godwin, C. D., Pagel, J. M., Buckley, S. A., . . . Sandmaier, B. M. (2014). Comparison of Minimal Residual Disease as Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation. Leukemia.
استشهاد بنمط شيكاغوWalter, Roland B., et al. "Comparison of Minimal Residual Disease As Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation." Leukemia 2014.
MLA استشهادWalter, Roland B., et al. "Comparison of Minimal Residual Disease As Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation." Leukemia 2014.